Mursla’s AI Precision Medicine is built on the ability to isolate and analyze EVs which are secreted by specific organs into ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly ...

Cancer pioneer Mursla Bio, which has bases in Cambridge UK and Boston MA, is expanding the reach of its precision diagnostics ...

Spatial metabolomics is transforming our understanding of microbial systems by uncovering the localized molecular dynamics ...

This valuable study identifies asymmetric dimethylarginine (ADMA) histones as potential determinants of the initial genomic binding of Rhino, a Drosophila-specific chromatin protein essential for ...

The global Nucleic Acid Isolation and Purification Market was valued at USD 902.9 million in 2020 and is projected to reach USD 1,174.1 million by 2025. From 2025 to 2035, the market is forecast to ...

Advances in the speed, scale, and affordability of nucleic acid synthesis over the last two decades have catalyzed a rapidly evolving landscape in ...

Scientists from the National University of Singapore (NUS) have developed NAPTUNE (Nucleic Acids and Protein biomarkers ...

Nucleic acids (DNA or RNA) are polymers of nucleotides – each nucleotide consists of a pentose sugar, a phosphate group and one of the nitrogenous bases (purines and pyrimidines). Nucleic acids ...

Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

The NANOSPRESSO system has high potential to enable the point-of-care production of nucleic acid-loaded LNPs, bypassing the logistical and scalability limitations of centralized manufacturing. Its ...